These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5761849)

  • 1. Prolongation of certain effects of amphetamine by chlorpromazine.
    Borella L; Herr F; Wojdan A
    Can J Physiol Pharmacol; 1969 Jan; 47(1):7-13. PubMed ID: 5761849
    [No Abstract]   [Full Text] [Related]  

  • 2. Potentiation and blockade of the central action of amphetamine by chlorpromazine.
    Sulser F; Dingell JV
    Biochem Pharmacol; 1968 Apr; 17(4):634-6. PubMed ID: 5649556
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of bovine fibrinopeptides on the central action of chlorpromazine and amphetamine in rats.
    Buczko W
    Acta Neurobiol Exp (Wars); 1976; 36(4):447-54. PubMed ID: 983820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some neuropharmacological and behavioural effects of an active fraction from Herpestis monniera, Linn (Brahmi).
    Ganguly DK; Malhtora CL
    Indian J Physiol Pharmacol; 1967 Jan; 11(1):33-43. PubMed ID: 5630157
    [No Abstract]   [Full Text] [Related]  

  • 5. Circadian variations in response to amphetamine and chlorpromazine in the rat.
    Wolfe GW; Bousquet WF; Schnell RC
    Commun Psychopharmacol; 1977; 1(1):29-37. PubMed ID: 606469
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nomifensine and body temperature of the rat: interaction with reserpine, chlorpromazine and amphetamine].
    Puche E; Mundo A; García Morillas M; Baeyens JM; Bolaños J
    Arch Farmacol Toxicol; 1979 Aug; 5(2):123-32. PubMed ID: 533317
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced sensitivity to noradrenergic agonists and tolerance development to -methyltyrosine in the rat.
    Beuthin FC; Miya TS; Blake DE; Bousquet WF
    J Pharmacol Exp Ther; 1972 Jun; 181(3):446-56. PubMed ID: 5033011
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of some CNS depressants on the hypermotility and anorexia induced by amphetamine in rats.
    Borella LE; Paquette R; Herr F
    Can J Physiol Pharmacol; 1969 Oct; 47(10):841-7. PubMed ID: 5259591
    [No Abstract]   [Full Text] [Related]  

  • 9. Modification by propranolol and related compounds of motor activity and stereotype behaviour induced in the rat by amphetamine.
    Weinstock M; Speiser Z
    Eur J Pharmacol; 1974 Jan; 25(1):29-35. PubMed ID: 4279823
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of aziprine on the central nervous system].
    Ponomareva AG
    Farmakol Toksikol; 1969; 32(4):403-6. PubMed ID: 5357457
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of chlorpromazine and d-amphetamine in Long Evans rats of different age, body weight and brain weight.
    Sofia RD
    Arch Int Pharmacodyn Ther; 1969 Nov; 182(1):139-46. PubMed ID: 5365229
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological studies on 2-methyl-4-amino-6-methoxy-s-triazine (CV399); with special reference to its central effects].
    Chiba S; Nagawa Y; Yui T
    Nihon Yakurigaku Zasshi; 1970; 66(1):64-75. PubMed ID: 4393359
    [No Abstract]   [Full Text] [Related]  

  • 13. Striatal homovanillic acid levels in rats after combined treatments with amphetamine and neuroleptics.
    Fuentes JA; Del Rio J
    Eur J Pharmacol; 1972 Feb; 17(2):297-300. PubMed ID: 5026405
    [No Abstract]   [Full Text] [Related]  

  • 14. Antagonism of psychostimulant 2-phenyl-5,5-dimethyl-tetrahydro-1,4-oxazine hydrochloride (G 130) to central nervous system depressing drugs. Monoamine oxidase inhibitory activity and norepinephrine and serotonin induced changes. Comparison with dL-amphetamine.
    Fanelli O; Mazzoncini V; Trallori L
    Arzneimittelforschung; 1974 Dec; 24(12):2025-9. PubMed ID: 4480283
    [No Abstract]   [Full Text] [Related]  

  • 15. Modification by L-DOPA methylester (H 19-61) of amphetamine-induced brain catecholamine changes, thermal responses and toxicity in developing mice.
    Alhava E
    Acta Pharmacol Toxicol (Copenh); 1973; 33(5):330-47. PubMed ID: 4801079
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine antagonism and antischizophrenic potency of neuroleptic drugs.
    Crow TJ; Gillbe C
    Nat New Biol; 1973 Sep; 245(140):27-8. PubMed ID: 4516939
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system.
    Sieroslawska J; Hano J; Sypniewska M; Czarnecki R; Chojnacka-Wójcik E; Harasiewicz A
    Pol J Pharmacol Pharm; 1973; 25(1):1-16. PubMed ID: 4798097
    [No Abstract]   [Full Text] [Related]  

  • 18. Study on the excitation induced by amphetamine, cocaine and alpha-methyltryptamine.
    Galambos E; Pfeifer AK; György L; Molnár J
    Psychopharmacologia; 1967; 11(2):122-9. PubMed ID: 5588184
    [No Abstract]   [Full Text] [Related]  

  • 19. Further studies on the interaction between desipramine and amphetamine.
    Dolfini E; Tansella M; Valzelli L; Garattini S
    Eur J Pharmacol; 1969 Jan; 5(2):185-90. PubMed ID: 5781971
    [No Abstract]   [Full Text] [Related]  

  • 20. Anorectic activity of some amphetamine-derivatives with low CNS stimulating potency.
    Gemignani A; Versace P; Cugurra F; Vaccari A
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):88-101. PubMed ID: 4643290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.